Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Raynaud's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00707187
What this trial is testing

Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction

Who this might be right for
Systemic Sclerosis
University of Medicine and Dentistry of New Jersey 120
Not applicableStudy completedNCT03699436
What this trial is testing

Effectiveness of Electric Stimulation Therapy in Raynaud's Phenomenon

Who this might be right for
Raynaud PhenomenonRaynaud Disease
Universidad de Granada 60
Very early researchStudy completedNCT03027674
What this trial is testing

Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud

Who this might be right for
Raynaud Phenomenon Due to TraumaRaynaud DiseaseSystem; Sclerosis+3 more
Pontificia Universidad Catolica de Chile 10
Testing effectiveness (Phase 2)Study completedNCT00378521
What this trial is testing

Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon

Who this might be right for
Raynaud's DiseaseRaynaud's Disease Secondary to SclerodermaRaynaud's Disease Secondary to Autoimmune Disease
MediQuest Therapeutics 15
Testing effectiveness (Phase 2)UnknownNCT02551042
What this trial is testing

CSL Behring Sclero XIII

Who this might be right for
Systemic Sclerosis
University College, London 26
Testing effectiveness (Phase 2)WithdrawnNCT06460194
What this trial is testing

Treatment of Frostbite Sequelae With Botulinum Toxin A

Who this might be right for
Cold HypersensitivityVascular System InjuriesVibration; Disorder+2 more
University Hospital of North Norway
Large-scale testing (Phase 3)Study completedNCT02050360
What this trial is testing

"As Required" Oral Sildenafil in Raynaud's Phenomenon

Who this might be right for
Raynaud's Phenomenon
University Hospital, Grenoble 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07748000
What this trial is testing

LIQ861 (Inhaled Treprostinil) in Adults With Systemic Sclerosis Who Have Symptomatic Raynaud's Phenomenon Attacks

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
Liquidia Technologies, Inc. 75
Not applicableUnknownNCT02183779
What this trial is testing

PORH and Response to Cold in Raynaud's Phenomenon.

Who this might be right for
Raynaud DiseaseHyperemiaCold
University Hospital, Grenoble 60
Not applicableUnknownNCT03984422
What this trial is testing

Application for Monitoring and Evaluation of Raynaud's Phenomenon

Who this might be right for
Raynaud Phenomenon
University Hospital, Grenoble 120
Testing effectiveness (Phase 2)Study completedNCT03867097
What this trial is testing

Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2)

Who this might be right for
Raynaud Phenomenon Secondary to Systemic Sclerosis
Civi Biopharma, Inc. 34
Not applicableEnded earlyNCT03869008
What this trial is testing

Potential Benefit for Non Invasive Vagus Nerve Stimulation Using GammaCore in the Treatment of Raynaud's Phenomena.

Who this might be right for
Raynaud PhenomenonPrimary Raynaud PhenomenonRaynaud Disease+1 more
University of Toledo Health Science Campus 6
Not applicableStudy completedNCT03211325
What this trial is testing

Identification of TRP Channels as New Potential Therapeutic Targets in Primary and Secondary Raynaud's Phenomenon.

Who this might be right for
Raynaud's Phenomenon Isolated PrimaryRaynaud's Phenomenon (Secondary)Healthy
University Hospital, Grenoble 29
Testing effectiveness (Phase 2)Study completedNCT00251238
What this trial is testing

Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynaud´s Phenomenon

Who this might be right for
Raynaud Disease
VSM Geneesmiddelen b.v. 41
Testing effectiveness (Phase 2)Study completedNCT01926847
What this trial is testing

Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator

Who this might be right for
Raynaud Disease
Bayer 23
Post-approval studies (Phase 4)Not Yet RecruitingNCT07240649
What this trial is testing

Emerging Indications for Hyperbaric Oxygen Treatment

Who this might be right for
Post-COVID-19 ConditionUlcerative ColitisCrohn Disease+38 more
Jay C. Buckey Jr. 100
Large-scale testing (Phase 3)Ended earlyNCT02374320
What this trial is testing

Exparel as a Nerve Block for Severe Hand Pain

Who this might be right for
CREST SyndromePeripheral Vascular DiseaseRaynaud Disease+1 more
Jose Soberon, MD 13
Not applicableStudy completedNCT01233999
What this trial is testing

Botulinum Toxin in the Treatment of Raynaud's

Who this might be right for
Raynaud's Syndrome
Emory University 10
Large-scale testing (Phase 3)Study completedNCT04040322
What this trial is testing

Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3)

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
Civi Biopharma, Inc. 198
Not applicableStudy completedNCT02212249
What this trial is testing

Soluble VE-cadherin and VE-cadherin Antibody in Sclerodermic Sclerosis

Who this might be right for
Primary Raynaud DiseaseSystemic Sclerosis
University Hospital, Grenoble 85
Next Page